INMUNE BIO INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $35.00K.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $1.00K.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $1.14M.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $18.00K.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.00K, a 99.76% decline from fiscal 2024.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for fiscal 2024 was $422.00K.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for fiscal 2022 was $30.00K, a 97.36% decline from fiscal 2021.
- INMUNE BIO INC. stock issued during period, value, stock options exercised for fiscal 2021 was $1.14M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $35.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $1.00K 10-K · filed 2026-03-30 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $422.00K 10-K · filed 2026-03-30 | |
| 2022-12-31 | $30.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $1.14M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $1.14M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $18.00K 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |